Skip to main content
. Author manuscript; available in PMC: 2017 Jul 10.
Published in final edited form as: Exp Neurol. 2013 May 24;248:53–61. doi: 10.1016/j.expneurol.2013.05.011

Fig. 3.

Fig. 3

Systemic treatment with deferasirox reduces peripheral iron content. A) Urinary iron content was doubled at 1 dpi in control animals compared to pre-injury levels. Urine from rats receiving deferasirox had significantly more iron compared to pre-injury values and to 1 dpi vehicle-treated values. B) One week after daily deferasirox treatments (160 mg/kg/day), liver iron content was significantly decreased. C) Representative images of liver sections stained for iron in black showing a significant reduction in hepatic iron following deferasirox treatment. A: ***p < 0.001 deferasirox 1 dpi vs. vehicle 1 dpi; ^^^p < 0.01 deferasirox 1 dpi vs. naïve baseline. B: *p < 0.05 deferasirox vs. control and vehicle.